Bioptik Technology Incorporation (TPEX:4161)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.45
-1.00 (-3.93%)
Mar 9, 2026, 1:30 PM CST
-20.83%
Market Cap 1.46B
Revenue (ttm) 837.19M
Net Income (ttm) 71.19M
Shares Out 59.81M
EPS (ttm) 1.21
PE Ratio 20.21
Forward PE n/a
Dividend 0.27 (1.04%)
Ex-Dividend Date n/a
Volume 41,016
Average Volume 74,314
Open 25.15
Previous Close 25.45
Day's Range 24.45 - 25.15
52-Week Range 23.72 - 31.59
Beta 0.32
RSI 35.72
Earnings Date Mar 6, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. It offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch Glucose Monitoring System for Dogs and Cats. The company also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1999
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4161
Full Company Profile

Financial Performance

In 2025, TPEX:4161's revenue was 837.19 million, a decrease of -3.25% compared to the previous year's 865.34 million. Earnings were 71.19 million, a decrease of -23.92%.

Financial Statements

News

There is no news available yet.